Acumed announced that the first wrist fixation surgery using its Acu-Loc NEXT system was completed by Dr. David Ruch, MD, Professor of Orthopaedic Surgery, and Dr. Marc Richard, MD, Professor of Orthopaedic Surgery of Duke University Hospital in Durham, North Carolina.

“The case was challenging,” said Dr. Richard. “The beauty of it was that the NEXT System preserved the things that I knew and trusted about the current system and allowed me to address some of the subtleties of the fracture with the nuanced instrumentation and tools and tricks for treating a very difficult distal radius fracture.” 

The company said Acu-Loc NEXT was designed by a team of renowned surgeons to advance fixation of wrist fractures. It’s built on the company’s 35-year legacy of innovation and the success of the original Acu-Loc launched in 2004.

Acu-Loc NEXT features a redesigned screw platform with advanced features, streamlined instrumentation, and clinically driven enhancements. The enhancements can help surgeons deliver personalized care, whether working on complex or routine cases.

The system earned U.S. Food and Drug Administration (FDA) clearance in August 2025. The company said over a million patients globally have regained motion, strength, and function with Acu-Loc implants.

“For over 20 plus years the Acu-Loc brand has set the standard in wrist fracture fixation in the healthcare community,” said Hjalmar Pompe van Meerdevoort, president of Acumed. “Acu-Loc NEXT is truly where the legacy of our ingenuity meets the innovation of our clinical partners and is what will continue to elevate that standard to meet our customers’ needs, allowing Acumed to be a true Partner of Choice.”

Last month, the company acquired assets from TECHFIT Digital Surgery, a partner in its craniomaxillofacial (CMF) patient-tailored solutions portfolio.